C8936 – Magnetic resonance angiography without contrast followed by with contrast, upper extremity

Long description

Magnetic resonance angiography without contrast followed by with contrast, upper extremity

Short description

Mra, w/o&w/dye, upper extr

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

I2D Advanced imaging - MRI/MRA: other

ASC

Approved for ambulatory surgical centers

Added

October 1, 2010

Last change

October 1, 2010 – No change

Nearby C codes

• C8928 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report
• C8929 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
• C8930 – Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision
• C8931 – Magnetic resonance angiography with contrast, spinal canal and contents
• C8932 – Magnetic resonance angiography without contrast, spinal canal and contents
• C8933 – Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents
• C8934 – Magnetic resonance angiography with contrast, upper extremity
• C8935 – Magnetic resonance angiography without contrast, upper extremity
• C8937 – Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)
• C8957 – Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
• C9014 – Injection, cerliponase alfa, 1 mg
• C9015 – Injection, c-1 esterase inhibitor (human), haegarda, 10 units
• C9016 – Injection, triptorelin extended release, 3.75 mg
• C9021 – Injection, obinutuzumab, 10 mg
• C9022 – Injection, elosulfase alfa, 1mg
• C9023 – Injection, testosterone undecanoate, 1 mg